Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine

By Jaworski J.N.   Gonzales R.A.   Randall P.K.  

European Journal of Pharmacology, Vol. 418, Iss. 3, 2001-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity

By Hertel P.   Byskov L.   Didriksen M.   Arnt J.  

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 77-81

Elsevier

Access to resources Recommend Favorite

Characterization of binding sites of a new neurotensin receptor antagonist, [ 3 H]SR 142948A, in the rat brain

By Betancur C.   Canton M.   Burgos A.   Labeeuw B.   Gully D.   Rostene W.   Pelaprat D.  

European Journal of Pharmacology, Vol. 343, Iss. 1, 1998-02 ,pp. : 67-77

Elsevier

Access to resources Recommend Favorite

GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice

By Quartaroli M.   Fasdelli N.   Bettelini L.   Maraia G.   Corsi M.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 219-227

Elsevier

Access to resources Recommend Favorite

M100907, a selective 5-HT 2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

By Habara T.   Hamamura T.   Miki M.   Ohashi K.   Kuroda S.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 189-194

Elsevier

Access to resources Recommend Favorite